Pacific Biosciences of California Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $10.65 on 12/27/23, and the lowest price during the same period was recorded at $1.16 on 07/02/24.
52-week price history of PACB Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Pacific Biosciences of California Inc’s current trading price is -81.88% away from its 52-week high, while its distance from the 52-week low is 66.38%. The stock’s price range during this period has fluctuated between $1.16 and $10.65. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 9.07 million for the day, which was evidently lower than the average daily volume of 9.56 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Pacific Biosciences of California Inc (PACB) has experienced a quarterly rise of 44.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 573.60M and boasts a workforce of 796 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7971, with a change in price of +0.4300. Similarly, Pacific Biosciences of California Inc recorded 9,580,730 in trading volume during the last 100 days, posting a change of +28.67%.
PACB Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 2.03. Similarly, the long-term debt-to-equity ratio is also 2.01.
PACB Stock Stochastic Average
Pacific Biosciences of California Inc’s raw stochastic average for the past 50 days is currently at 39.46%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 35.77%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 30.62% and 26.29%, respectively.
PACB Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -80.33%. However, over the past six months, we’ve seen a weaker performance of 3.21%. The price of PACB leaped by -11.06% over the last 30 days. And in the last five days, it has surged by 7.22%.
